Efficacy of intramuscular BCG polysaccharide nucleotide on mild to moderate bronchial ashtma accompanied with allergic rhinitis: A randomized, double blind, placebo-controlled study

Chinese Medical Journal

Volumn 118, Issue 19, 2005, Pages 1595-1603

  Li, Jing ^a   Luo, Ding Fen ^a   Li, Sui Ying ^a   Sun, Bao Qing ^a   Zhong, Nan Shan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Allergic rhiitis; Ashtma; Bacillus Calmette Gu rin polysaccharide nucleotide

Indexed keywords

BECLOMETASONE; BRONCHODILATING AGENT; CORTICOSTEROID; HISTAMINE; IMMUNOGLOBULIN E; LORATADINE; PLACEBO; POLYSACCHARIDE; SALBUTAMOL;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE CONTROL; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG RESPONSE; DRUG UTILIZATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN TEST;

ADULT; ASTHMA; BCG VACCINE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; MALE; MIDDLE AGED; NUCLEOTIDES; POLYSACCHARIDES, BACTERIAL; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SKIN TESTS;

EID: 27144472265     PISSN: 03666999     EISSN: 03666999     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Xie ZF, Shi HZ, Qin XJ, et al. Effects of antigen presentation of eosinophils on lung Th1/Th2 imbalance. Chin Med J 2005;118:6-11.
2. Shi HZ. Eosinophils in asthma. Chin Med J 2004;117: 792-794.
3. Choi IS, Koh YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trail. Ann Allergy Asthma Immunol 2002;88: 584-591.
4. Choi IS, Koh YI. Effects of BCG revaccination on asthma. Allergy 2003;58:1114-1116.
5. Orme IM, Andersen P, Boom WH, et al. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993;167:1481-1497.
6. Shirakawa T, Enomoto T, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-79.
7. von Mutius E, Pearce N, Beasley R, et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000;55:449-453.
8. Erb KJ, Holloway JW, Sobeck A, et al. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosino-philia. J Exp Med 1998;187:561-569.
9. Herz U, Gerhold K, Gruber C, et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867-874.
10. Wang CC, Rook GA. Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology 1998; 93: 307-313.
11. Wong GW, Hui DS, Tam CM, et al. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong. Thorax 2001;56:770-773.
12. Strannegard IL, Larsson LO, Wennergren G, et al. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998;53:249-254.
13. Wen YX, Luo YZ, Zhang SH, et al. Consecutive 5-year observation of predominant deactivated BCG in treatment of pediatric indolent bronchioasthma. Tian Jin Med (Chin) 1987;3:155-157.
14. Huo ZZ, Liao ZX, Wu YB, et al. Inactivated BCG injection in the management of asthma (100 cases report). Guangzhou Med J (Chin) 1984;15:16-18.
15. Gao JS, Xie ZD, Fang JZ, et al. The application of BCG polysacchariede nucleic acid in the management of childhood asthma. Acta Hu Nan Med Univ (Chin) 1992;17:365-367.
16. Aas K. Some variables in skin prick testing. Allergy 1980;35:250-252.
17. Bousquet J, Chanez P, Chanal I, et al. Comparison between RAST and Pharmacia CAP System: a new automate specific IgE assay. J Allergy Clin Immunol 1990;85:1039-1043.
18. Ewan PW, Coote D. Evaluation of a capsulated hydrophilic carrier polymer (the Immuno CAP) for measurement of specific IgE antibodies. Allergy 1990; 45:22-29.
19. Strannegard IL, Larsson LO, Wennergren G, et al. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998;53:249-254.
20. Omenaas E, Jentoft HF, Vollmer WM, et al. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 2000; 55: 454-458.
21. Shirtcliffe PM, Easthope SE, Weatherall M, et al. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guerin in adult asthma. Clin Exp Allergy 2004;34:207-212.
22. von Hertzen LC, Haahtela T. Could the risk of asthma and atopy be reduced by a vaccine that induces a strong T-helper type 1 response? Am J Respir Cell Mol Biol 2000;22:139-142.
23. The Research Committee of the British Thoracic Association. Effectiveness of BCG vaccination in Great Britain in 1978. Br J Dis Chest 1980;74:215-227.
24. Chatterjee D, Khoo KH. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound phusiologic effects. Glycobiology 1998; 8:113-120.
25. Young DB, Kaufmann SH, Hermans PW, et al. Mycobacterial protein antigens: a compilation. Mol Microbiol 1992;6:133-145.
26. Sun S, Kishimoto H, Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxy-nucleotides to augment T cell responses to specific antigen. J Exp Med 1998;187:1145-1150.
27. Prigozy TI, Sieling PA, Clemens D, et al. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 1997;6:187-197.
28. Roach TI, Barton CH, Chatterjee D. Macrophage activation: lipoarabinomannan from avirulent and virulent strins of Mycobacterium tuberculosis differentially induce the early genes c-fos, KC, JE, and tumor necrosis facor-alpha. J Immunol 1993;150:1886-1896.
29. Yamomoto S, Kuramoto E, Shimada S, et al. In vitro augmentation of naturl killer cell activity and production of interferon-α/β and -γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988;79:866-873.
30. Yamamoto S, Yamamoto T, Kataoka E, et al. Unique palindromic sequences in synthetic oligonucleotides are required to induce INF and augment INF-mediated natural killer activity. 1992;148:4072-4076.
31. Fujieda S, Iho S, Kimura Y, et al. DNA from Mycobacterium bovis bacillus Calmette-Guerin (MY-1) inhibits immunoglobulin E production by human lymphocytes. Am J Respir Crit Care Med. 1999; 160: 2056-2061.
32. Renz H, Herz U. The bidirectional capacity of bacterial antigens to modulate allergy and asthma. Eur Respir J 2002;19:158-171.
33. Lee N, Gelfand E, Lee J. Pulmonary T cells and eosinophils: pathology? J Allergy Clin Immunol 2001; 107:945-957.
34. Holtzman MJ, Sampath D, Castro M, et al. The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol 1996;14:316-318.
35. Hanson G, Berry G, DeKruyff R, et al. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175-183.